Università Vita Salute San Raffaele, Milano, Italy.
FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27.
Plasma membrane urokinase-type plasminogen activator (uPA)-receptor (uPAR) is a GPI-anchored protein that binds with high-affinity and activates the serine protease uPA, thus regulating proteolytic activity at the cell surface. In addition, uPAR is a signaling receptor that often does not require its protease ligand or its proteolytic function. uPAR is highly expressed during tissue reorganization, inflammation, and in virtually all human cancers. Since its discovery, in vitro and in vivo models, as well as retrospective clinical studies have shown that over-expression of components of the uPA/uPAR-system correlates with increased proliferation, migration, and invasion affecting the malignant phenotype of cancer. uPAR regulates the cells-extracellular matrix interactions promoting its degradation and turnover through the plasminogen activation cascade.
血浆膜尿激酶型纤溶酶原激活物(uPA)-受体(uPAR)是一种糖基磷脂酰肌醇(GPI)锚定蛋白,它以高亲和力结合并激活丝氨酸蛋白酶 uPA,从而调节细胞表面的蛋白水解活性。此外,uPAR 是一种信号受体,通常不需要其蛋白酶配体或其蛋白水解功能。uPAR 在组织重组、炎症和几乎所有人类癌症中高度表达。自发现以来,体外和体内模型以及回顾性临床研究表明,uPA/uPAR 系统成分的过度表达与增殖、迁移和侵袭的增加相关,从而影响癌症的恶性表型。uPAR 通过纤溶酶原激活级联反应调节细胞-细胞外基质相互作用,促进其降解和周转。